ID   AML14.3D10
AC   CVCL_0141
SY   AML14-3D10; AML143D10
DR   MCCL; MCC:0000034
DR   ABM; T8172
DR   GEO; GSM1374391
DR   Kerafast; EWR002
DR   Wikidata; Q54749806
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9474744;
CC   Doubling time: 48 hours (Kerafast=EWR002).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8286 ! AML14 [Human leukemia]
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
CH   CVCL_6337 ! AML14.3D10/CCCKR3 Clone 16
//
RX   PubMed=9474744; DOI=10.1002/stem.160016;
RA   Baumann, Michael A.
RA   Paul, Cassandra C.
RT   "The AML14 and AML14.3D10 cell lines: a long-overdue model for the
RT   study of eosinophils and more.";
RL   Stem Cells 16:16-24(1998).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//